Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
14 hedge funds and large institutions have $211K invested in Histogen Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
133% more capital invested
Capital invested by funds: $90.4K → $211K (+$121K)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
8% more funds holding
Funds holding: 13 → 14 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$49.1K |
| 2 |
Millennium Management
New York
|
+$28K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16.3K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$2.87K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.91K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$10.9K |
| 2 |
Renaissance Technologies
New York
|
-$9K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.18K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$34 |
HSTO Hedge Fund Activity: Q1 2023 in Review
14 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q1 2023, worth a combined $211K — up 133% from $90.4K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new HSTO positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $49.1K. The largest seller was Jane Street, exiting entirely with an estimated $10.9K sold.
- 14 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q1 2023, up from 13 in Q4 2022.
- Funds reported $211K of Histogen Inc. Common Stock stock for Q1 2023, up 133% quarter-over-quarter.
- 4 funds opened new Histogen Inc. Common Stock positions in Q1 2023 and 3 closed out, a net change of +1 holder.
- The largest Histogen Inc. Common Stock buyer in Q1 2023 was Vanguard Group, an estimated $49.1K added.
- The largest Histogen Inc. Common Stock seller in Q1 2023 was Jane Street, an estimated $10.9K sold.
Based on aggregated 13F filings for Q1 2023.